Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 9337 | 39.76 |
09:34 ET | 3886 | 39.83 |
09:36 ET | 1925 | 39.82 |
09:38 ET | 400 | 39.815 |
09:39 ET | 3768 | 39.95 |
09:41 ET | 1100 | 40.08 |
09:43 ET | 3178 | 39.965 |
09:45 ET | 359 | 39.965 |
09:48 ET | 1797 | 39.895 |
09:50 ET | 200 | 39.85 |
09:52 ET | 600 | 39.9 |
09:54 ET | 4910 | 39.97 |
09:56 ET | 1271 | 39.965 |
09:57 ET | 900 | 39.99 |
09:59 ET | 774 | 40.11 |
10:01 ET | 400 | 40.08 |
10:03 ET | 675 | 39.98 |
10:06 ET | 500 | 40.01 |
10:08 ET | 500 | 39.96 |
10:10 ET | 1578 | 39.91 |
10:12 ET | 890 | 39.855 |
10:14 ET | 1214 | 39.72 |
10:15 ET | 3525 | 39.635 |
10:17 ET | 1285 | 39.68 |
10:19 ET | 1655 | 39.65 |
10:21 ET | 893 | 39.755 |
10:24 ET | 100 | 39.795 |
10:26 ET | 200 | 39.825 |
10:28 ET | 400 | 39.85 |
10:32 ET | 500 | 39.93 |
10:33 ET | 541 | 39.97 |
10:35 ET | 307 | 40.01 |
10:37 ET | 100 | 40.015 |
10:39 ET | 1571 | 40.04 |
10:42 ET | 2390 | 40.08 |
10:44 ET | 2400 | 40.1 |
10:46 ET | 1260 | 40.13 |
10:48 ET | 1610 | 40.16 |
10:50 ET | 1110 | 40.13 |
10:51 ET | 300 | 40.13 |
10:53 ET | 388 | 40.13 |
10:55 ET | 1733 | 40.2352 |
10:57 ET | 2110 | 40.21 |
11:00 ET | 2259 | 40.24 |
11:02 ET | 609 | 40.3 |
11:04 ET | 650 | 40.32 |
11:06 ET | 2300 | 40.315 |
11:08 ET | 977 | 40.305 |
11:09 ET | 3000 | 40.34 |
11:11 ET | 625 | 40.3553 |
11:13 ET | 4189 | 40.315 |
11:15 ET | 1100 | 40.3 |
11:18 ET | 300 | 40.29 |
11:20 ET | 700 | 40.315 |
11:22 ET | 927 | 40.315 |
11:24 ET | 2300 | 40.4 |
11:26 ET | 325 | 40.4096 |
11:27 ET | 920 | 40.4 |
11:29 ET | 215 | 40.36 |
11:31 ET | 1292 | 40.375 |
11:33 ET | 1200 | 40.43 |
11:36 ET | 1250 | 40.33 |
11:38 ET | 520 | 40.42 |
11:40 ET | 300 | 40.415 |
11:42 ET | 300 | 40.44 |
11:44 ET | 4177 | 40.46 |
11:45 ET | 200 | 40.44 |
11:47 ET | 300 | 40.46 |
11:49 ET | 500 | 40.44 |
11:51 ET | 5836 | 40.45 |
11:54 ET | 1900 | 40.49 |
11:56 ET | 2600 | 40.47 |
11:58 ET | 300 | 40.45 |
12:02 ET | 712 | 40.48 |
12:03 ET | 1347 | 40.465 |
12:05 ET | 100 | 40.465 |
12:09 ET | 2000 | 40.48 |
12:12 ET | 1047 | 40.48 |
12:14 ET | 224 | 40.485 |
12:16 ET | 100 | 40.5 |
12:18 ET | 4135 | 40.37 |
12:20 ET | 200 | 40.385 |
12:21 ET | 700 | 40.34 |
12:23 ET | 1175 | 40.315 |
12:25 ET | 270 | 40.32 |
12:27 ET | 640 | 40.3 |
12:30 ET | 1365 | 40.32 |
12:32 ET | 611 | 40.355 |
12:34 ET | 427 | 40.36 |
12:36 ET | 200 | 40.38 |
12:38 ET | 1046 | 40.405 |
12:39 ET | 200 | 40.39 |
12:41 ET | 793 | 40.4 |
12:43 ET | 200 | 40.42 |
12:45 ET | 600 | 40.4 |
12:48 ET | 1700 | 40.36 |
12:50 ET | 599 | 40.365 |
12:52 ET | 400 | 40.37 |
12:54 ET | 500 | 40.34 |
12:56 ET | 1400 | 40.16 |
12:57 ET | 200 | 40.14 |
12:59 ET | 1054 | 40.1 |
01:03 ET | 1225 | 40.043 |
01:06 ET | 800 | 40.035 |
01:08 ET | 700 | 40.04 |
01:10 ET | 100 | 40.04 |
01:12 ET | 1100 | 40.065 |
01:14 ET | 2685 | 39.935 |
01:15 ET | 200 | 39.92 |
01:17 ET | 1280 | 39.95 |
01:19 ET | 3552 | 39.935 |
01:21 ET | 680 | 39.875 |
01:24 ET | 200 | 39.85 |
01:26 ET | 400 | 39.825 |
01:28 ET | 1200 | 39.83 |
01:30 ET | 6964 | 39.87 |
01:32 ET | 2029 | 39.86 |
01:33 ET | 100 | 39.73 |
01:35 ET | 700 | 39.755 |
01:37 ET | 1477 | 39.75 |
01:39 ET | 3338 | 39.805 |
01:42 ET | 1853 | 39.79 |
01:44 ET | 700 | 39.82 |
01:46 ET | 800 | 39.855 |
01:48 ET | 300 | 39.86 |
01:50 ET | 1616 | 39.875 |
01:51 ET | 1949 | 39.85 |
01:53 ET | 300 | 39.81 |
01:55 ET | 300 | 39.76 |
01:57 ET | 200 | 39.73 |
02:00 ET | 300 | 39.7 |
02:02 ET | 100 | 39.66 |
02:04 ET | 2534 | 39.73 |
02:06 ET | 300 | 39.78 |
02:08 ET | 300 | 39.78 |
02:09 ET | 100 | 39.765 |
02:11 ET | 300 | 39.765 |
02:13 ET | 700 | 39.83 |
02:15 ET | 300 | 39.81 |
02:18 ET | 300 | 39.79 |
02:20 ET | 1195 | 39.81 |
02:22 ET | 314 | 39.79 |
02:24 ET | 7318 | 39.78 |
02:26 ET | 14457 | 39.845 |
02:27 ET | 1700 | 39.795 |
02:29 ET | 835 | 39.67 |
02:31 ET | 13600 | 39.665 |
02:33 ET | 1300 | 39.63 |
02:36 ET | 205 | 39.61 |
02:38 ET | 33942 | 39.78 |
02:40 ET | 1975 | 39.81 |
02:42 ET | 1500 | 39.84 |
02:44 ET | 600 | 39.84 |
02:45 ET | 1905 | 39.91 |
02:47 ET | 1533 | 39.9 |
02:49 ET | 4392 | 39.82 |
02:51 ET | 707 | 39.69 |
02:54 ET | 1935 | 39.74 |
02:56 ET | 2229 | 39.733 |
02:58 ET | 1374 | 39.675 |
03:00 ET | 200 | 39.69 |
03:02 ET | 1195 | 39.67 |
03:03 ET | 6168 | 39.78 |
03:05 ET | 830 | 39.8 |
03:07 ET | 2013 | 39.84 |
03:09 ET | 1858 | 39.88 |
03:12 ET | 2500 | 39.93 |
03:14 ET | 1640 | 40 |
03:16 ET | 2012 | 40.02 |
03:18 ET | 9539 | 39.85 |
03:20 ET | 1800 | 39.875 |
03:21 ET | 3807 | 39.725 |
03:23 ET | 4876 | 39.66 |
03:25 ET | 2293 | 39.74 |
03:27 ET | 1842 | 39.8 |
03:30 ET | 2060 | 39.79 |
03:32 ET | 2268 | 39.78 |
03:34 ET | 1700 | 39.79 |
03:36 ET | 4195 | 39.751 |
03:38 ET | 25977 | 39.77 |
03:39 ET | 2943 | 39.8 |
03:41 ET | 3817 | 39.745 |
03:43 ET | 1410 | 39.71 |
03:45 ET | 3396 | 39.75 |
03:48 ET | 4113 | 39.72 |
03:50 ET | 6183 | 39.71 |
03:52 ET | 10439 | 39.89 |
03:54 ET | 17981 | 39.96 |
03:56 ET | 22075 | 39.83 |
03:57 ET | 20748 | 39.87 |
03:59 ET | 166911 | 39.87 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 5.5B | -14.9x | --- |
Halozyme Therapeutics Inc | 5.6B | 18.9x | --- |
Apellis Pharmaceuticals Inc | 4.8B | -12.0x | --- |
ACADIA Pharmaceuticals Inc | 2.5B | -1,190.4x | --- |
Azenta Inc | 2.7B | -19.2x | --- |
CRISPR Therapeutics AG | 4.6B | -22.1x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.5B |
---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.35 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -14.9x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -45.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.